RepRegen

RepRegen

RepRegen develops a hard tissue repair and regeneration platform to be used by orthopedic product manufacturers and surgeons.

Launch date
Employees
Market cap
-
Enterprise valuation
€6—9m (Dealroom.co estimates Nov 2010.)
Company register number 05846910
London England (HQ)
  • Edit
DateInvestorsAmountRound

N/A

Spinout

$1.6m

Early VC
Total Funding€1.5m

Recent News about RepRegen

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.